My watch list
my.bionity.com  
Login  
NEWS
Current news

Cyberonics And Sorin Group To Merge

Sorin S.p.A. and Cyberonics Inc. announced their merger plan to create a new global leader in medical technologies with a combined equity value of approximately $2.7 billion (€2.4 billion) based on the closing price of Sorin and Cyberonics shares on 25 February.The proposed transaction has ... more

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix paediatric study

Biogen Idec and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in children under age 12 with severe haemo ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Olive oil: the key to curing cancer?

Extra virgin olive oil (EVOO), long-known for its heart health benefits, has now been identified for its rapid destruction of cancer cells. While scientists have proven that the oleocanthal compound found in EVOO causes cell death in cancer cells, they have been unable to provide an explana ... more

Nebraska’s Ebola isolation and decontamination approach

The Nebraska Biocontainment Unit (NBU), located at the Nebraska Medical Center, has shared its protocol for Ebola patient discharge, handling a patient’s body after death and environmental disinfection in the American Journal of Infection Control. Discharge process for a patient treated for ... more

Apeiron announces start of phase I trail with cellular anti cancer therapy

Apeiron Biologics AG announced that a first patient has been treated as part of a phase I clinical trial with Apeiron’s individual cellular therapy APN401. The investigator-initiated trial is performed at Wake Forest Baptist Medical Center (WFBMC) led by Pierre L. Triozzi, professor of inte ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

CSIRO maintains foundational patent for RNAi gene silencing technology after European opposition

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), has successfully defended its foundational patent in Europe for RNA interference (RNAi) gene silencing technology. RNAi technology is a powerful method that is widely used as a research tool to test the function of ge ... more

Untangling DNA with a droplet of water, a pipet and a polymer

Researchers have long sought an efficient way to untangle DNA in order to study its structure – neatly unraveled and straightened out – under a microscope. Now, chemists and engineers at KU Leuven have devised a strikingly simple and effective solution: they inject genetic material into a d ... more

Researchers Hone in on Stem Cell that Speeds Healing of Stubborn Diabetes Wounds

A new study published in STEM CELLS Translational Medicine reveals how a particular type of stem cell generated from fat tissue may outperform other types of stem cells in speeding up the healing of wounds caused by type 1 diabetes. In the study, ulcers in a mice model treated with these ce ... more

All news

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

Technology Partnership between Berthold Technologies & Biametrics

Berthold Technologies has recently established a co-operation with its new technology partner Biametrics GmbH. A spin-off of Tübingen University, Biametrics develops novel solutions for label-free analysis of bio-interactions. The 1λ-Reflectometric Interference Detection (1λ-RIDe) is the mi ... more

Huntingdon Life Sciences and Harlan Laboratories to operate under new brand and name

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations. One of the world’s leadin ... more

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests

As the era of personalized medicine dawns on healthcare, the need to understand an individual’s genetic information through genomic testing has risen. This emerging branch of medicine has given birth to multiple companies that provide genetic tests to help end users understand their genetic ... more

The promiscuity of chemical probes discovered

Researchers at IMIM (Hospital del Mar Medical Research Institute) have applied a new computational methodology to anticipate the degree of selectivity of the molecules that are used to study protein functions and reduce the risk of establishing erroneous relations between proteins and disea ... more

Eurofins acquires BioDiagnostics, Inc.

Eurofins Scientific announces the acquisition of BioDiagnostics Inc. (BDI), seed and plant-tissue testing laboratories serving the agricultural industry in the US.Founded in 1996, BDI employs 120 staff at its laboratory in River Falls, WI. BDI offers genetic, seed quality, as well as analyt ... more

Mutation detection in human in vitro fertilized embryos using whole-genome sequencing

Pre-implantation genetic diagnosis (PGD) is used in fertility clinics to detect large chromosomal abnormalities or genetic mutations passed on by parents to their in vitro fertilized (IVF) embryos. However, it is not possible to comprehensively scan the embryo's genome to detect spontaneous ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

Plasticell wins £1.6 million funding

Plasticell has announced that Innovate UK has made a further investment in a therapeutic programme utilising CombiCult®, the high throughput stem cell technology designed to solve bottlenecks in regenerative medicine development. Innovate UK will provide a grant of approximately £1.3 millio ... more

Five new categories for Bio Business Awards

Five new award categories have been added to this year’s Bio Business Awards, designed to reward exciting and new innovations as well as tenacity in leadership within the industry.  As a tribute to 10 years of World Bio Markets being at the forefront of the industry, 10 categories have been ... more

All news on bioanalytics

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

CSIRO maintains foundational patent for RNAi gene silencing technology after European opposition

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), has successfully defended its foundational patent in Europe for RNA interference (RNAi) gene silencing technology. RNAi technology is a powerful method that is widely used as a research tool to test the function of ge ... more

Untangling DNA with a droplet of water, a pipet and a polymer

Researchers have long sought an efficient way to untangle DNA in order to study its structure – neatly unraveled and straightened out – under a microscope. Now, chemists and engineers at KU Leuven have devised a strikingly simple and effective solution: they inject genetic material into a d ... more

Researchers Hone in on Stem Cell that Speeds Healing of Stubborn Diabetes Wounds

A new study published in STEM CELLS Translational Medicine reveals how a particular type of stem cell generated from fat tissue may outperform other types of stem cells in speeding up the healing of wounds caused by type 1 diabetes. In the study, ulcers in a mice model treated with these ce ... more

XstalBio Ltd: US Patent Issued for Stabilization of Therapeutic Proteins

XstalBio Ltd announced the United States Patent and Trademark Office has issued US Patent, US 8,932,715,  covering the use of precipitation stabilising additives for manufacture of dry powders of therapeutic proteins, including monoclonal antibodies (mAbs). Applications in development inclu ... more

World’s first cancer stem cell model from iPS cells

Professor Masaharu Seno at the Department of Biotechnology of Okayama University, reports that cancer stem cells produced from mouse iPS cells are actually necessary for the maintenance of the cancer cells themselves. This research sheds light on the mechanism governing the development of c ... more

Trial could lead to new treatment for most common form of muscular dystrophy

Patients with the most common form of muscular dystrophy, Duchenne, often lose the ability to walk by the time they reach age 12 and typically only live to reach their 20s. Now, University of Florida Health researchers are participating in a key late-stage clinical trial that could lead to ... more

United Kingdom Becomes Only Country to Allow Human Germline Modification

The vote on February 24th in the UK House of Lords means that variations of embryonic genetic modification may soon be used in fertility clinics without any required follow-up of resulting children, despite extensive scientific, ethical, and legal objections heard from around the world. The ... more

Biofortuna Ltd appoints new chairman to lead next phase of growth

Biofortuna has appointed a new chairman to lead the next phase of growth.  Life sciences expert Ian Johnson will take on the role at Biofortuna with previous chairman Mark Hurley remaining on the board as a non-executive director.Ian has spent his business career in life sciences. He was fo ... more

The Gene Center at Ludwig-Maximilians-Universität München and ExpreS2ion Biotechnologies Enter a Licensing Agreement

ExpreS2ion Biotechnologies announced the signature of a research license agreement to provide the Gene Center at Ludwig-Maximilians-Universität München with access to its Drosophila Schneider-2 cell-based technology platform - ExpreS2 - for recombinant protein production. The stable, non-ly ... more

All news on biotechnology

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

Roche acquires Signature Diagnostics

Roche announced the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are cons ... more

New Endoscopic Technique

Fluorescence lifetime imaging (FLIM) of tissue autofluorescence has been shown to provide labelfree contrast between different types and states of tissue. Clinical FLIM can combine lifetime contrast with morphological information to provide a direct comparison between different spatial regi ... more

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis announces that it is in the testing phase of a Rapid Ebola Virus Triage Test that it is developing in association with Janssen Diagnostics and the Institute for Tropical Medicine in Antwerp (Belgium) for its Idylla™ system. The Rapid Ebola Virus Triage Test is designed to enable h ... more

Eurofins acquires of Boston Heart Diagnostics Corporation

Eurofins Scientific announces the successful closing of the transaction to acquire Boston Heart Diagnostics Corp. (Boston Heart) following review and approval from relevant regulatory bodies.Eurofins signed an agreement to acquire Boston Heart for an initial cash amount US$140 million, plus ... more

Premaitha Health receives ISO 13485:2003 certification

Premaitha Health plc  announced that it has met two key requirements for obtaining a CE-mark for its IONA® test: ISO 13485:2003 certification and a successful audit of Annex IV of the In Vitro Diagnostic Medical Device Directive (98/79/EC). The ISO 13485:2003 certification confirms that Pre ... more

European Hantavirus Diagnostics Market Tops US Market as a Result of Higher Disease Prevalence

The European Hantavirus diagnostics market is growing at a compound annual growth rate (CAGR) of 5.8 percent, outperforming the U.S. market, which registered 3.7 percent. The European market is more robust primarily due to Hantavirus’ high prevalence rates in Russia, Scandinavia, Finland an ... more

Gold nanoparticles show promise for early detection of heart attacks

NYU Polytechnic School of Engineering professors have been collaborating with researchers from Peking University on a new test strip that is demonstrating great potential for the early detection of certain heart attacks.Kurt H. Becker, a professor in the Department of Applied Physics and th ... more

All news on diagnostics

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

Merck announced that it has obtained antitrust clearance from the United States Federal Trade Commission (FTC) for its planned acquisition of US-based life science company Sigma-Aldrich. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with i ... more

Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.

Sartorius is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc. The respective contract was signed today. The sales price will be determined as a multiple of the Intec division’s 2014 operati ... more

Expansion of the WALDNER Group

The WALDNER Group, with its headquarters in Wangen, and Hohenloher Spezialmöbelwerke have joined forces on the market for laboratory furniture and furniture for scientific classrooms. Both corporations can look back on a tradition of more than 100 years. Waldner (approx. 1100 employees) is ... more

LAUDA founds subsidiary in Italy

The constant temperature equipment specialist LAUDA is expanding its international reach with the creation of LAUDA Italia. The purpose of the 100% subsidiary of LAUDA Beteiligungs-GmbH is to manage the increased expansion of business in the important European market. "In this company decis ... more

analytica China 2014: Closed with overall success

On September 26 analytica China 2014 closed with record-breaking visitor numbers: 18,775 business professionals (2012: 16,940) from 62 countries attended the seventh edition of Chinas Leading Trade Fair for Laboratory Technology, Analysis, Biotechnology and Diagnostics at the Shanghai New I ... more

Messe München International takes over one of India's leading trade fairs for laboratory technology

Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the first time ever, this year's India Lab E ... more

Bochem Increasingly Using New Media

Bochem Instrumente GmbH presents sections of its overall product spectrum in various new videos. The recently finished productions provide a compact overview of the product groups of lab jacks, electrical lifts, containers as well as stands and clamps. They can be found on the company’s web ... more

All news on lab technology

Cyberonics And Sorin Group To Merge

Sorin S.p.A. and Cyberonics Inc. announced their merger plan to create a new global leader in medical technologies with a combined equity value of approximately $2.7 billion (€2.4 billion) based on the closing price of Sorin and Cyberonics shares on 25 February.The proposed transaction has ... more

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix paediatric study

Biogen Idec and Swedish Orphan Biovitrum AB announced positive top-line results of the Kids B-LONG Phase 3 clinical study that evaluated the safety, efficacy and pharmacokinetics of Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in children under age 12 with severe haemo ... more

Apeiron announces start of phase I trail with cellular anti cancer therapy

Apeiron Biologics AG announced that a first patient has been treated as part of a phase I clinical trial with Apeiron’s individual cellular therapy APN401. The investigator-initiated trial is performed at Wake Forest Baptist Medical Center (WFBMC) led by Pierre L. Triozzi, professor of inte ... more

Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo

Sanofi announced that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is expected to be available i ... more

Bayer: All subgroups contribute to record sales and earnings

Bayer had a very successful year in 2014, both operationally and strategically. The company set new records for sales and for EBITDA before special items. “Contributing to this in particular was the continuing growth momentum in our Life Science businesses, and especially the pleasing devel ... more

Ipsen Enters Into Option Agreement to Acquire Canbex Therapeutics

Ipsen and Canbex Therapeutics Ltd announced that Canbex has granted Ipsen an option giving Ipsen the exclusive right to purchase 100% of Canbex shares upon completion of the Phase IIa study of Canbex’s lead candidate for the treatment of spasticity in people with multiple sclerosis (MS), kn ... more

Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round

Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures, the company's founding investor, will also participate.  This first funding will help Prexton Therapeutics to develop novel small molec ... more

Infant Bacterial Therapeutics gets Orphan Drug Designation in Europe

Infant Bacterial Therapeutics (IBT), subsidiary of BioGaia, is in the early stages of developing a drug to prevent necrotizing enterocolitis (NEC) which is a rare and fatal disease that affects premature infants. IBT has now obtained the Orphan Drug Designation for the prevention of NEC in ... more

Cyclenium Pharma and Fundación MEDINA Announce Drug Discovery and Collaboration Agreement

Cyclenium Pharma Inc. and Fundación MEDINA (Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, the University of Granada and Merck Sharp and Dohme de España S.A., announced the signing of a drug discovery and collaboration agreement. The collaboration ... more

An assembly line for medications

Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) and the Freie Universität Berlin have succeeded in developing better methods of producing APIs (active pharmaceutical ingredients). As a result, Efavirenz, one of the preferred agents for treating HIV in combination ... more

All news on pharma

Olive oil: the key to curing cancer?

Extra virgin olive oil (EVOO), long-known for its heart health benefits, has now been identified for its rapid destruction of cancer cells. While scientists have proven that the oleocanthal compound found in EVOO causes cell death in cancer cells, they have been unable to provide an explana ... more

Nebraska’s Ebola isolation and decontamination approach

The Nebraska Biocontainment Unit (NBU), located at the Nebraska Medical Center, has shared its protocol for Ebola patient discharge, handling a patient’s body after death and environmental disinfection in the American Journal of Infection Control. Discharge process for a patient treated for ... more

Researchers Hone in on Stem Cell that Speeds Healing of Stubborn Diabetes Wounds

A new study published in STEM CELLS Translational Medicine reveals how a particular type of stem cell generated from fat tissue may outperform other types of stem cells in speeding up the healing of wounds caused by type 1 diabetes. In the study, ulcers in a mice model treated with these ce ... more

Researchers Find Link between Persistent Insomnia and Increased Mortality Risk

A connection between persistent insomnia and increased inflammation and mortality has been identified by a group of researchers from the University of Arizona. Their study, published in The American Journal of Medicine, found that people who suffer from persistent insomnia are at greater ri ... more

World’s first cancer stem cell model from iPS cells

Professor Masaharu Seno at the Department of Biotechnology of Okayama University, reports that cancer stem cells produced from mouse iPS cells are actually necessary for the maintenance of the cancer cells themselves. This research sheds light on the mechanism governing the development of c ... more

Trial could lead to new treatment for most common form of muscular dystrophy

Patients with the most common form of muscular dystrophy, Duchenne, often lose the ability to walk by the time they reach age 12 and typically only live to reach their 20s. Now, University of Florida Health researchers are participating in a key late-stage clinical trial that could lead to ... more

Stem Cells from Pulled Teeth Might Yield a Cure for Blindness

Recent research aimed at finding a treatment for a common form of blindness could give new meaning to the term “eye teeth.” In a study in mice published in STEM CELLS Translational Medicine, researchers at the University of Pittsburgh show how stem cells harvested from teeth extracted durin ... more

Mechanical thrombectomy improves outcomes in acute ischemic stroke

Stroke resulting from rupture or interruption of blood flow in brain vessels can lead to devastating consequences for patients, their families and society. Steady progress has been achieved in the last 20 years in stroke treatment through better prevention, establishment of stroke care unit ... more

Proteins pull together as cells divide

Like a surgeon separating conjoined twins, cells have to be careful to get everything just right when they divide in two. Otherwise, the resulting daughter cells could be hobbled, particularly if they end up with too many or two few chromosomes. Successful cell division hangs on the formati ... more

Bacterial defense mechanism targets Duchenne Muscular Dystrophy

Duke researchers have demonstrated a genetic therapeutic technique that has the potential to treat more than half of the patients suffering from Duchenne Muscular Dystrophy (DMD). One of the challenges of treating DMD is that the disease can be caused by mutations to a number of different D ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE